V

Vor Biopharma Inc
NASDAQ:VOR

Watchlist Manager
Vor Biopharma Inc
NASDAQ:VOR
Watchlist
Price: 0.8098 USD 1.43% Market Closed
Market Cap: 55.4m USD
Have any thoughts about
Vor Biopharma Inc?
Write Note

Vor Biopharma Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vor Biopharma Inc
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
V
Vor Biopharma Inc
NASDAQ:VOR
Capital Expenditures
-$1.1m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Capital Expenditures
-$858m
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
-$572m
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
-5%
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
-$965m
CAGR 3-Years
-14%
CAGR 5-Years
-8%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
-$481.8m
CAGR 3-Years
-12%
CAGR 5-Years
-47%
CAGR 10-Years
-23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
-$886.1m
CAGR 3-Years
-15%
CAGR 5-Years
-20%
CAGR 10-Years
-14%

See Also

What is Vor Biopharma Inc's Capital Expenditures?
Capital Expenditures
-1.1m USD

Based on the financial report for Dec 31, 2023, Vor Biopharma Inc's Capital Expenditures amounts to -1.1m USD.

What is Vor Biopharma Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
36%

Over the last year, the Capital Expenditures growth was 87%. The average annual Capital Expenditures growth rates for Vor Biopharma Inc have been 36% over the past three years .

Back to Top